Dynamic Progression of White Matter Hyperintensities in Alzheimer's Disease and Normal Aging: Results from the Sunnybrook Dementia Study
- PMID: 27047377
- PMCID: PMC4805606
- DOI: 10.3389/fnagi.2016.00062
Dynamic Progression of White Matter Hyperintensities in Alzheimer's Disease and Normal Aging: Results from the Sunnybrook Dementia Study
Abstract
Although white matter hyperintensities (WMH), markers of cerebral small vessel disease (SVD), are believed to generally increase over time, some studies have shown sharp decreases after therapeutic intervention, suggesting that WMH progression may be more dynamic than previously thought. Our primary goal was to examine dynamic progression of WMH in a real-world sample of Alzheimer's disease (AD) patients and normal elderly (NC), with varying degrees of SVD. WMH volumes from serial magnetic resonance imaging (MRI; mean = 1.8 years) were measured from NC (n = 44) and AD patients (n = 113) with high and low SVD burden. Dynamic progression for each individual was measured using spatial overlap images to assess shrinkage, growth, and stable WMH volumes. Significant group differences were found for shrinkage (p < 0.001), growth (p < 0.001) and stable (p < 0.001) WMH, where the AD high SVD group showed the largest changes relative to low SVD and NC. Our results suggest spatial progression measured at the individual patient level may be more sensitive to the dynamic nature of WMH.
Keywords: Alzheimer’s disease; aging; dementia; longitudinal progression; small vessel disease; white matter hyperintensities.
Figures



Similar articles
-
Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer's disease patients and normal elderly from the Sunnybrook Dementia Study.J Alzheimers Dis. 2015;43(2):415-24. doi: 10.3233/JAD-132528. J Alzheimers Dis. 2015. PMID: 25096616
-
White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.J Neurol Sci. 2018 Feb 15;385:99-104. doi: 10.1016/j.jns.2017.12.018. Epub 2017 Dec 19. J Neurol Sci. 2018. PMID: 29406924
-
Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage.Front Neurosci. 2020 Mar 19;14:238. doi: 10.3389/fnins.2020.00238. eCollection 2020. Front Neurosci. 2020. PMID: 32265640 Free PMC article.
-
[White Matter Lesion and Alzheimer's Disease: The Association between Small Vessel Disease and Neuropsychiatric Symptoms in Alzheimer's Disease].Brain Nerve. 2015 Apr;67(4):427-32. doi: 10.11477/mf.1416200158. Brain Nerve. 2015. PMID: 25846591 Review. Japanese.
-
Associations Between White Matter Hyperintensity Burden, Cerebral Blood Flow and Transit Time in Small Vessel Disease: An Updated Meta-Analysis.Front Neurol. 2021 May 4;12:647848. doi: 10.3389/fneur.2021.647848. eCollection 2021. Front Neurol. 2021. PMID: 34017302 Free PMC article.
Cited by
-
The Effects of Longitudinal White Matter Hyperintensity Change on Cognitive Decline and Cortical Thinning over Three Years.J Clin Med. 2020 Aug 17;9(8):2663. doi: 10.3390/jcm9082663. J Clin Med. 2020. PMID: 32824599 Free PMC article.
-
Microstructural and metabolic changes in the longitudinal progression of white matter hyperintensities.J Cereb Blood Flow Metab. 2019 Aug;39(8):1613-1622. doi: 10.1177/0271678X18761438. Epub 2018 Mar 9. J Cereb Blood Flow Metab. 2019. PMID: 29519198 Free PMC article.
-
Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.PLoS One. 2017 Mar 2;12(3):e0172484. doi: 10.1371/journal.pone.0172484. eCollection 2017. PLoS One. 2017. PMID: 28253275 Free PMC article.
-
Neuropsychiatric symptoms as a sign of small vessel disease progression in cognitive impairment.Cereb Circ Cogn Behav. 2022 Jan 19;3:100041. doi: 10.1016/j.cccb.2022.100041. eCollection 2022. Cereb Circ Cogn Behav. 2022. PMID: 36324402 Free PMC article.
-
In vivo myelin imaging and tissue microstructure in white matter hyperintensities and perilesional white matter.Brain Commun. 2022 Jun 6;4(3):fcac142. doi: 10.1093/braincomms/fcac142. eCollection 2022. Brain Commun. 2022. PMID: 35694147 Free PMC article.
References
-
- Apostolova L. G., Green A. E., Babakchanian S., Hwang K. S., Chou Y. Y., Toga A. W., et al. . (2012). Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI) and Alzheimer Disease. Alzheimer Dis. Assoc. Disord. 26, 17–27. 10.1097/WAD.0b013e3182163b62 - DOI - PMC - PubMed
-
- Barnes J., Carmichael O. T., Leung K. K., Schwarz C., Ridgway G. R., Bartlett J. W., et al. . (2013). Vascular and Alzheimer’s disease markers independently predict brain atrophy rate in Alzheimer’s Disease Neuroimaging Initiative controls. Neurobiol. Aging 34, 1996–2002. 10.1016/j.neurobiolaging.2013.02.003 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources